methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate has been researched along with ovalbumin in 1 studies
Studies (methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate) | Trials (methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate) | Recent Studies (post-2010) (methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate) | Studies (ovalbumin) | Trials (ovalbumin) | Recent Studies (post-2010) (ovalbumin) |
---|---|---|---|---|---|
16 | 0 | 0 | 19,565 | 63 | 5,664 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Piper, PJ; Yaacob, HB | 1 |
1 other study(ies) available for methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate and ovalbumin
Article | Year |
---|---|
Inhibition of leukotriene release in anaphylactic guinea-pig hearts by a 5-lipoxygenase inhibitor, CGS 8515.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Anaphylaxis; Animals; Guinea Pigs; Heart; In Vitro Techniques; Lipoxygenase Inhibitors; Male; Naphthoquinones; ortho-Aminobenzoates; Ovalbumin; Perfusion; Prostaglandin-Endoperoxide Synthases; Pyrazoles; SRS-A | 1988 |